Form 8-K - Current report:
SEC Accession No. 0001555280-25-000209
Filing Date
2025-05-21
Accepted
2025-05-21 16:22:57
Documents
14
Period of Report
2025-05-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20250521.htm   iXBRL 8-K 27408
2 EX-99.1 exhibit9913q2025dividendpr.htm EX-99.1 11958
6 GRAPHIC image_0a.jpg GRAPHIC 16150
  Complete submission text file 0001555280-25-000209.txt   180547

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20250521.xsd EX-101.SCH 1848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20250521_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20250521_pre.xml EX-101.PRE 12574
16 EXTRACTED XBRL INSTANCE DOCUMENT zts-20250521_htm.xml XML 2695
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 25973452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)